A
AVTX
Avalo Therapeutics Inc
16.35
-0.25-1.51%After Hours: 16.35 0.00 0.00%16:10 05/22 EDT
OPEN/PREV CLOSE16.60/16.60
TODAY RANGE16.02-17.01
VOL1.32M
MARKET CAP859.45M
52 WEEK RANGE3.431-24.27
AVG VOL (3M)1.42M
% TURNOVER2.51%
TURNOVER--
P/E (TTM)-2.8027
% RANGE5.96%
EPS(TTM)-5.8336
P/E(FORWARD)-6.5927
P/B5.90
BVPS2.773
DIVIDEND--
P/S5,109.38
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP837.88M
SHARES OUTSTANDING52.57M
NEXT EARNINGS08/05-08/10
FREE FLOAT51.25M
LOT SIZE1
EX-DATE12/29/2023
News
Press Releases
Financial Reports
Profile
TipRanks·05/14 17:17
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
Dow Jones·05/14 14:19
Avalo Therapeutics Is Maintained at Market Outperform by Citizens
Dow Jones·05/14 14:19
Avalo Therapeutics Price Target Cut to $55.00/Share From $62.00 by Citizens
Dow Jones·05/14 13:21
Avalo Therapeutics Is Maintained at Outperform by Wedbush
Dow Jones·05/14 13:21
Avalo Therapeutics Price Target Cut to $34.00/Share From $40.00 by Wedbush
Benzinga·05/14 13:18
These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Results
Benzinga·05/14 13:11
Wedbush Maintains Outperform on Avalo Therapeutics, Lowers Price Target to $34
Benzinga·05/14 12:41
Apple To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday
Dow Jones·05/14 12:15
Avalo Therapeutics Price Target Raised to $45.00/Share From $39.00 by Mizuho
Dow Jones·05/14 12:15
Avalo Therapeutics Is Maintained at Outperform by Mizuho
Same Industry
Name/Symbol
Change%
Price